S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Warren Buffett again encourages investors to bet on America
pixel
Biden hails House passage of $1.9T virus bill, now to Senate
Pandemic leaves tribes without US recognition at higher risk
The Latest: U.S. FDA approves J&J single-shot vaccine
Biden team readies wider economic package after virus relief
In oil-rich Iraq, a few women buck norms, take rig site jobs
The Latest: Collins: Reconsider U.S.-Canada border limits
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Warren Buffett again encourages investors to bet on America
pixel
Biden hails House passage of $1.9T virus bill, now to Senate
Pandemic leaves tribes without US recognition at higher risk
The Latest: U.S. FDA approves J&J single-shot vaccine
Biden team readies wider economic package after virus relief
In oil-rich Iraq, a few women buck norms, take rig site jobs
The Latest: Collins: Reconsider U.S.-Canada border limits
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Warren Buffett again encourages investors to bet on America
pixel
Biden hails House passage of $1.9T virus bill, now to Senate
Pandemic leaves tribes without US recognition at higher risk
The Latest: U.S. FDA approves J&J single-shot vaccine
Biden team readies wider economic package after virus relief
In oil-rich Iraq, a few women buck norms, take rig site jobs
The Latest: Collins: Reconsider U.S.-Canada border limits
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Warren Buffett again encourages investors to bet on America
pixel
Biden hails House passage of $1.9T virus bill, now to Senate
Pandemic leaves tribes without US recognition at higher risk
The Latest: U.S. FDA approves J&J single-shot vaccine
Biden team readies wider economic package after virus relief
In oil-rich Iraq, a few women buck norms, take rig site jobs
The Latest: Collins: Reconsider U.S.-Canada border limits
Log in
ASX:RNO

Rhinomed Earnings Date, Estimates & History

Add
Compare
Today's Range N/A
50-Day Range
A$0.07
MA: A$0.07▼
A$0.07
52-Week Range N/A
Volume452,773 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

Rhinomed Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Rhinomed (ASX RNO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/28/2019S1 2019A($0.02)N/A
8/30/2018Y 2018A($0.04)N/A
3/13/2018S1 2018A($0.02)N/A
2/27/2018S1 2018A($0.02)N/A
8/28/2017Y 2017A($0.07)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/28/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.